New PBS list­ings

Pharmacy Daily - - Front Page -

HEALTH Min­is­ter Greg Hunt an­nounced on Fri­day the fund­ing for Phar­ma­ceu­ti­cal Ben­e­fits Scheme (PBS) list­ing of a ther­apy for suf­fer­ers of seizures as­so­ci­ated with a rare ge­netic dis­ease.

Affin­i­tor (everolimus) from No­var­tis helps pa­tients with tuber­ous scle­ro­sis com­plex (TSC); they are af­flicted with be­nign tu­mours im­pact­ing the ner­vous sys­tem and fre­quently ex­pe­ri­ence as many as 50 seizures a day.

Also newly PBS-listed is Ot­suka Aus­tralia Phar­ma­ceu­ti­cals’ Ji­narc (tolvap­tan) which is now be­ing re­im­bursed for the treat­ment of au­to­so­mal dom­i­nant poly­cys­tic kid­ney dis­ease (ADPKD) which is es­ti­mated to af­fect about 10,000 Aus­tralian pa­tients.

Ji­narc blocks the ac­tiv­ity of the nat­u­rally oc­cur­ring hor­mone va­so­pressin, which is el­e­vated in ADPKD pa­tients and con­trib­utes to the growth of cysts on the kid­neys.

Newspapers in English

Newspapers from Australia

© PressReader. All rights reserved.